Copyright 2022 - Custom text here

Absinthism: fictitious 19th century syndrome - <b>References </b>

Article Index


Hemphill RE: The illness of Vincent Van Gogh. Proc R Soc Med 1961, 54:1083-1088.

Blumer D: The illness of Vincent van Gogh. Am J Psychiatry 2002, 159:519-526.

Arnold WN: Vincent van Gogh and the thujone connection. JAMA 1988, 260:3042-3044.

Lee TC: Van Gogh's vision. Digitalis intoxication? JAMA 1981, 245:727-9.

Arnold WN, Loftus LS: Xanthopsia and van Gogh's yellow pal ette. Eye 1991, 5:503-510.

Loftus LS, Arnold WN: Vincent van Gogh's illness: acute inter mittent porphyria? BMJ 1991, 303:1589-91.

Arnold WN: The Illness of Vincent van Gogh. J Hist Neurosci 2004, 13:22-43.

Council Directive (EEC) No 88/388 on the approximation of the laws of the Member States relating to flavourings for use in foodstuffs and to source materials for their production. Off J Europ Comm 1988, L184:61-66.

The Papyrus Ebers: The greatest Egyptian medical document translated by

B. Ebell Copenhagen, Levin & Munksgaard; 1937.

Baker P: The book of absinthe: a cultural history New York, USA, Grove Press; 2001.

Pliny the Elder: Book XXVII. Chap. 28. Absinthium or wormwood. In The natural history Edited by: Bostock J and Riley HT. London, UK, Taylor and Francis; 1855.

Smith G: A compleat body of distilling, explaining the mysteries of that science, in a most easy and familiar manner London, Henry Lintot; 1731:136-138.

Lanier D: Absinthe-the cocaine of the nineteenth century: a history of the hallucinogenic drug and its effect on artists and writers in Europe and the United States Jefferson, North Carolina, USA, McFarland; 1995.

Paris JA: Pharmacologia, 4th American Edition New York, W. E. Dean; 1831:79.

The conquest of absinthe -French national curse suppressed. The Times, Issue 40819 1915, Apr 03:7.

Adams J: Hideous Absinthe. A history of the devil in a bottle Madison, USA, The University of Wisconsin Press; 2004.

Lachenmeier DW, Frank W, Athanasakis C, Padosch SA, Madea B, Rothschild MA, Kröner LU: Absinthe, a spirit drink -its history and future from a toxicological-analytical and food regulatory point of view. Deut Lebensm-Rundsch 2004, 100:117-129.

Prestwich PE: Temperance in France: the curious case of absinth. Hist Reflect 1979, 6:301-319.

Arnold WN: Absinthe. Sci Am 1989, 260:112-117.

Arnold WN: Vincent van Gogh: chemicals, crises, and creativity Boston, Birkhäuser; 1992.

Conrad B: Absinthe. History in a bottle. San Francisco, CA, Chronicle Books; 1988.

Marrus MR: Social drinking in the belle epoque. J Soc Hist 1974, 7:115-141.

Hood WP: Absinthe and its artifacts. Magazine Antiques 2005, 167:134-143.

Bundesversammlung: Bundesgesetz betreffend das Absinthverbot. Schweiz Wochschr Chem Pharm 1910, 48:677-678.

Schweizer Bundesrat: Vollziehungsgesetz zum Bundesgesetz betreffend das Absinthverbot. Schweiz Wochschr Chem Pharm 1910, 48:678-679.

Brannt WT: A practical treatise on the raw materials and the distillation and rectification of alcohol, and the preparation of alcoholic liquors, liqueurs, cordials, and bitters Philadelphia, USA, Henry Capey Bairs & Co.; 1885.

Fritsch J: Nouveau traité de la fabrication des liqueurs d'aprés les procédés les plus récents Paris, France, G. Masson; 1891.

de Brevans J: La fabrication des liqueurs Paris, France, J.-B. Bailliére et fils; 1908.

Ströhmer G: Rohstoffe und Halbfabrikate zur Herstellung von Likören. In Spirituosen-Technologie Edited by: Kolb E. Hamburg, Germany, Behr's Verlag; 2002:161-343.

Duplais P: Traité de la fabrication des liqueurs et de la distillation des alcools Paris, France, Gauthier-Villars; 1882.

Bedel A: Traité complet de la fabrication des liqueurs Paris, France, Garnier Frères; 1899.

Goettler H: Lexikon der Spirituosen- und alkoholfreien Getränke-Industrie 4th edition. Berlin, Germany, Carl Knoppke Grüner Verlag; 1958.

Lancet: Medical Annotations: Absinthism. Lancet 1873, 101:22.

Emerson ER: Beverages, Past and Present - A historical sketch of their production, together with a study of the customs connected with their use. Volume II New York and London, G P Putnam's Sons; 1908:176-177.

Tibbles W: Foods - their origin, composition and manufacture London, Ballière, Tindall and Cox; 1912.

Vogt DD, Montagne M: Absinthe: behind the emerald mask. Int J Addict 1982, 17:1015-1029.

Walker EE: The effects of absinthe. Med Rec 1906, Oct. 13:568-572.

Amory R: Experiments and observations on absinth and absinthism. Boston Med Surg J 1868:68-71-83-85.

Lamy L: Étude de statistique clinique de 134 cas de cancer de l'œsophage et du cardia. Archives des maladies de l'appareil digestif et des malnutrition 1910, 4:451-456.

Corning JL: The efficacy of wormwood (Artemisia absinthium) in certain conditions of the cerebrospinal axis. Med Rec 1890, Jan. 25:88-89.

Dowbiggin I: Back to the future: Valentin Magnan, French psy chiatry, and the classification of mental diseases, 1885-1925. Soc Hist Med 1996, 9:383-408.

Magnan V: Accidents déterminés par l'abus de la liqueur d'absinthe. L'union médicale 1864, 92&94:227-232-257-262.

Magnan V: On the comparative action of alcohol and absinthe. Lancet 1874, 104:410-412.

Holstege CP, Baylor MR, Rusyniak DE: Absinthe: return of the Green Fairy. Semin Neurol 2002, 22:89-93.

Magnan V, Fillassier A: Alcoholism and Degeneracy. Statistics of the Central Service for the Admission of Insane Persons for the town of Paris and for the Department of the Seine, from 1867-1912. In Problems in Eugenics. Papers communicated to the First International Eugenics Conference held at the University of London July 24th to 30th, 1912 Adelphi,W.C., The Eugenics Education Society; 1912.

Bonkovsky HL, Cable EE, Cable JW, Donohue SE, White EC, Greene YJ, Lambrecht RW, Srivastava KK, Arnold WN: Porphyrogenic properties of the terpenes camphor, pinene, and thujone (with a note on historic implications for absinthe and the ill ness of Vincent van Gogh). Biochem Pharmacol 1992, 43:2359-2368.

Lancet: Absinthe and alcohol. Lancet 1869, 93:334.

Baker KD: Vivisection debate in nineteenth century Great Britain: a muted echo in colonial and early post-colonial Aus tralia. Aust Vet J 1998, 76:683-689.

Boyce R: A Contribution to the study of descending degenarations in the brain and spinal cord, and of the seat of origin and paths of conduction of the fits in absinthe epilepsy. Phil Transact Royal Soc 1895:321-382.

Ott I: The seat of absinthic epilepsy. J Nerv Ment Dis 1892, 19:696-698.

Ossipow WP: Über die Dosierung der Absinthessenz (essence d'absinthe cultivée) beim Hervorrufen von Anfällen experimenteller Epilepsie bei Hunden. Monatsschr Psychiatr Neurol 1914, 85:516-525.

Cunningham RH: The restoration of coordinated, volitional movement after nerve "crossing". Am J Physiol 1898, 1:239-254.

Lesieur C: Nouvelles Recherches sur la toxicité expérimentale des essences usuelles. Archives de médecine expérimentale et d'anatomie pathologique 1907, 18:803-817.

Magnan: The degenerate. American Journal of insanity 1895, 52:193-198.

JAMA: The indiscriminate use of alcohol. JAMA 1900, 35:1632-1633.

Strang J, Arnold WN, Peters T: Absinthe: what's your poison? Br Med J 1999, 319:1590-1592.

Carnat AP, Madesclaire M, Chavignon O, Lamaison JL: cis-Chrysan-thenol, a main component in essential oil of Artemisia absinthium L. growing in Auvergne (Massif Central), France. J Essent Oil Res 1992, 4:487-490.

Ariño A, Arberas I, Renobales G, Arriaga S, Dominguez JB: Essential oil of Artemisia absinthium L. from the Spanish Pyrenees. J Essent Oil Res 1999, 11:182-184.

Mucciarelli M, Caramiello R, Maffei M: Essential Oils from some Artemisia species growing spontaneously in North-West Italy. Flavour Fragr J 1995, 10:25-32.

Chialva F, Liddle PAP, Doglia G: Chemotaxonomy of wormwood (Artemisia absinthium L.) I. Composition of the essential oil of several chemotypes. Z Lebensm Unters Forsch 1983, 176:363-366.

Vostrowsky O, Brosche T, Ihm H, Zintl R, Knobloch K: Über die Komponenten des ätherischen Öls aus Artemisia absinthium L. Z Naturforsch 1981, 36c:369-377.

Pino JA, Rosado A, Fuentes V: Chemical composition of the essential oil of Artemisia absinthium L. from Cuba. J Essent Oil Res 1997, 9:87-89.

Sacco T, Chialva F: Chemical characteristics of the oil from Artemisia absinthium collected in Patagony (Argentina). Planta Med 1988, 54:93.

Nin S, Arfaioli P, Bosetto M: Quantitative determination of some essential oil components of selected Artemisia absinthium plants. J Essent Oil Res 1995, 7:271-277.

WHO: Thujone. Toxicological Evaluation of certain food additives WHO food additives series 16 1981.

Scientific Committee on Food of the European Commission: Opinion of the Scientific Committee on Food on Thujone comm/food/fs/sc/scf/index_en.html; 2003.

Codex Alimentarius Commission of the FAO/WHO: Report of the 13th session of the codex committee on food additives.

Alinorm 79/12-A 1979.

EDI: Verordnung des EDI über Fremd- und Inhaltsstoffe in Lebensmitteln. SR 2002, 817.021.23:.

FDA: Code of Federal Regulations - 21CFR172.510 cfr; 2005.

U.S.Customs and Border Protection: Prohibited and Restricted Items prohibited_restricted.xml; 2006.

Turner J: Green Gold. The return of absinthe. The New Yorker 2006, March 13:38-44.

Höld KM, Sirisoma NS, Ikeda T, Narahashi T, Casida JE: α-Thujone (the active component of absinthe): γ -aminobutyric acid

type A receptor modulation and metabolic detoxification. Proc Natl Acad Sci U S A 2000, 97:3826-3831.

Dettling A, Grass H, Schuff A, Skopp G, Strohbeck-Kuehner P, Haffner HT: Absinthe: attention performance and mood under the influence of thujone. J Stud Alcohol 2004, 65:573-581.

Olsen RW: Absinthe and γ -aminobutyric acid receptors. Proc Natl Acad Sci U S A 2000, 97:4417-4418.

Sirisoma NS, Höld KM, Casida JE: α- and β-Thujones (herbal medicines and food additives): synthesis and analysis of hydroxy and dehydro metabolites. J Agric Food Chem 2001, 49:1915-1921.

Höld KM, Sirisoma NS, Casida JE: Detoxification of α- and β -Thu- jones (the active ingredients of absinthe): site specificity and species differences in cytochrome P450 oxidation in vitro and in vivo. Chem Res Toxicol 2001, 14:589-595.

Deiml T, Haseneder R, Zieglgänsberger W, Rammes G, Eisensamer B, Rupprecht R, Hapfelmeier G: α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-reduced desensitization. Neuropharmacology 2004, 46:192-201.

Behrens M, Brockhoff A, Kuhn C, Bufe B, Winni g M, Meyerhof W:

The human taste receptor hTAS2R14 responds to a variety of different bitter compounds. Biochem Biophys Res Commun 2004, 319:479-485.

He X, de Montellano PRO: Radical rebound mechanism in cyto chrome P-450-catalyzed hydroxylation of the multifaceted radical clocks alpha- and beta-thujone. J Biol Chem 2004, 279:39479-39484.

De Smet PA: Health risks of herbal remedies: an update. Clin Pharmacol Ther 2004, 76:1-17.

Smith W: A case of poisoning by oil of wormwood (Artemisia absinthium). Lancet 1862, 80:619.

Weisbord SD, Soule JB, Kimmel PL: Poison on line -acute renal failure caused by oil of wormwood purchased through the Internet. N Engl J Med 1997, 337:825-827.

Max B: This and that: cheap drinks and expensive drugs. TiPS 1990, 11:56-60.

Hinkelbein J: Absinth - the renaissance of the green fairy. Aktuel Ernaehr Med 2004, 29:138-141.

Kröner LU, Lachenmeier DW, Käferstein H, Rothschild M, Madea B, Padosch SA: Investigations on the medico-legal relevance of spirits containing thujone with special regard to toxicologi-cal-analytical aspects. Blutalkohol 2005, 42:263-271.

BfR: Fashionable beverage absinth: BfR advises consumers to exercise caution with this product! Berlin, Germany, Federal Institute for Risk Assessment Press release 15/2003; 2003.

Meschler JP, Howlett AC: Thujone exhibits low affinity for can nabinoid receptors but fails to evoke cannabimimetic responses. Pharmacol Biochem Behav 1999, 62:473-480.

Hutton I: Myth, reality and absinthe. Curr Drug Discov 2002, 9:62-64.

Wilson JB: Determination of thujone in absinthe-type liqueurs. J AOAC 1936, 19:120-124.

Ronnet L: Analyse des absinthes du commerce. Annales des Falsifications et des Fraudes 1911, 3:477-479.

Balavoine P: A propos de la thuyone dans les absinthes et ses imitations. Mitt Geb Lebensm Hyg 1952, 43:195-196.

Rocques MX: Caractérisation et dosage de l'essence d'absinthe dans les liqueurs. Annales de Chimie Analytique et Revue de Chimie Analytique Réunies 1908, 13:227-232.

Enz H: Zum Nachweis des Thujons im Absinth. Schweiz Wochschr Chem Pharm 1911, 49:337-340.

Mérat E, Martin E, Duret M, Vogel J: Extraction et dosage par chromatographie en phase gazeuse de β-asarone et de α- et β-thuyone dans les apéritifs. Trav chim aliment hyg 1976, 67:521-526.

Lachenmeier DW, Emmert J, Kuballa T, Sartor G: Thujone-Cause of absinthism? Forensic Sci Int 2006, 158:1-8.

Krumm B, Kölling R, Senn T: Thujongehalte von Wermut-Extrakten bei unterschiedlichen Extraktionsbedingungen. Lebensmittelchem 2006, 60:accepted, in press.

Ashcraft B: The mystery of the green menace. Wired Magazine 2005, 13.11:.

Schaefer I, Bindler F, Lugnier A: Toxicological rehabilitation of absinthium liqueur. Toxicol Lett 1994, 74 Suppl. 1:75.

99. Luauté JP, Saladini O, Benyaya J: Neuropsychiatric toxicity of absinthe. History, current data. Ann Med Psychol (Paris) 2005, 163:497-501.

100. Hein J, Lobbedey L, Neumärker KJ: Absinth - Neue Mode, alte Probleme. Dt Ärztebl 2001, 98:A2716-A2724.

101. Müller O: Wermut - gefährliches Kraut in harmloser Verpackung. Zahnärztl Mitt 2002, 92:78.

102. Lachenmeier DW, Emmert J, Sartor G: Authentification of absinthe - the bitter truth over a myth. Deut Lebensm-Rundsch 2005, 101:100-104.

103. Zolotow M: Absinthe. Playboy 1971, June:169-174.

104. del Castillo J, Anderson M, Rubottom GM: Marijuana, absinthe and the central nervous system. Nature 1975, 253:365-366.

105. Corelli M: Wormwood-A drama of Paris London, UK, Richard Bentley and Son; 1890.

106. Thomé OW: Flora von Deutschland, Österreich und der Schweiz Gera, Germany, Köhler; 1885.

107. NTP: Summary of data for chemical selection Alpha-Thujone 546-80-5 The National Toxicology Program; 2005. 108. Surber W: Etude de toxicité sous-chronique de la thujone sur rats. Rapport

final Genève, Institute Batelle; 1962.

Email: Stephan A Padosch This email address is being protected from spambots. You need JavaScript enabled to view it.; Dirk W Lachenmeier* This email address is being protected from spambots. You need JavaScript enabled to view it.; Lars U Kröner This email address is being protected from spambots. You need JavaScript enabled to view it.

* Corresponding author †Equal contributors

Published: 10 May 2006

Received: 28 March 2006

Substance Abuse Treatment, Prevention, and Policy 2006, 1:14


Accepted: 10 May 2006

 This article is available from:

© 2006 Padosch et al; licensee BioMed Central Ltd.
This is an Open Access articl e distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


f t g m